Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coactivator activity	TRERF1 NCOA2 BCL9L NCOA3 NCOA6 TSC22D1 KMT2D BCL9	4.05e-07	303	46	8	GO:0003713
GeneOntologyMolecularFunction	nuclear estrogen receptor binding	NCOA2 NCOA3 NCOA6 ISL1	6.64e-06	53	46	4	GO:0030331
GeneOntologyMolecularFunction	molecular adaptor activity	TRERF1 NCOA2 BCL9L NCOA3 NCOA6 TSC22D1 KMT2D UBQLN2 SGTB BCL9 SGTA EIF4G1 TNRC6A	7.58e-06	1356	46	13	GO:0060090
GeneOntologyMolecularFunction	nuclear receptor coactivator activity	TRERF1 NCOA2 NCOA3 NCOA6	1.17e-05	61	46	4	GO:0030374
GeneOntologyMolecularFunction	transcription coregulator activity	TRERF1 NCOA2 BCL9L NCOA3 NCOA6 TSC22D1 KMT2D BCL9	3.81e-05	562	46	8	GO:0003712
GeneOntologyMolecularFunction	nuclear thyroid hormone receptor binding	NCOA2 NCOA3 NCOA6	6.51e-05	34	46	3	GO:0046966
GeneOntologyMolecularFunction	nuclear receptor binding	TRERF1 NCOA2 NCOA3 NCOA6 ISL1	6.85e-05	187	46	5	GO:0016922
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	TRERF1 NCOA2 BCL9L NCOA3 NCOA6 TSC22D1 KMT2D UBQLN2 BCL9 TNRC6A	2.52e-04	1160	46	10	GO:0030674
GeneOntologyMolecularFunction	polyubiquitin modification-dependent protein binding	UBQLN2 UBQLN1 UBQLN4	3.40e-04	59	46	3	GO:0031593
GeneOntologyMolecularFunction	AP-2 adaptor complex binding	AAK1 TBC1D5	4.64e-04	14	46	2	GO:0035612
GeneOntologyMolecularFunction	histone methyltransferase binding	NCOA6 RESF1	7.76e-04	18	46	2	GO:1990226
GeneOntologyMolecularFunction	protein domain specific binding	DAB1 NCOA2 DOCK4 NCOA3 NCOA6 ISL1 UBQLN1 CHMP2B	7.81e-04	875	46	8	GO:0019904
GeneOntologyMolecularFunction	nuclear glucocorticoid receptor binding	NCOA2 NCOA6	9.61e-04	20	46	2	GO:0035259
GeneOntologyMolecularFunction	peroxisome proliferator activated receptor binding	NCOA3 NCOA6	1.06e-03	21	46	2	GO:0042975
GeneOntologyMolecularFunction	nuclear retinoid X receptor binding	NCOA2 NCOA6	1.27e-03	23	46	2	GO:0046965
GeneOntologyMolecularFunction	chromatin binding	NCOA2 NCOA3 NCOA6 ISL1 TOX POLQ NFAT5	1.41e-03	739	46	7	GO:0003682
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	TRERF1 NCOA2 NCOA3 NCOA6 ISL1	2.63e-03	417	46	5	GO:0061629
GeneOntologyBiologicalProcess	positive regulation of intracellular steroid hormone receptor signaling pathway	NCOA2 NCOA3 KMT2D	8.27e-06	18	46	3	GO:0033145
GeneOntologyBiologicalProcess	nuclear receptor-mediated steroid hormone signaling pathway	TRERF1 NCOA2 NCOA3 KMT2D ISL1	1.28e-05	136	46	5	GO:0030518
GeneOntologyBiologicalProcess	regulation of clathrin-dependent endocytosis	AAK1 SMAP1 UBQLN2	1.34e-05	21	46	3	GO:2000369
GeneOntologyBiologicalProcess	positive regulation of ERAD pathway	UBQLN2 UBQLN1 SGTA	1.55e-05	22	46	3	GO:1904294
GeneOntologyBiologicalProcess	steroid hormone receptor signaling pathway	TRERF1 NCOA2 NCOA3 KMT2D ISL1	2.40e-05	155	46	5	GO:0043401
GeneOntologyBiologicalProcess	intracellular receptor signaling pathway	TRERF1 NCOA2 NCOA3 KMT2D ISL1 UBQLN1 CD36	3.50e-05	416	46	7	GO:0030522
GeneOntologyBiologicalProcess	regulation of ERAD pathway	UBQLN2 UBQLN1 SGTA	3.64e-05	29	46	3	GO:1904292
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	TRERF1 NCOA2 BCL9L NCOA3 NCOA6 TSC22D1 KMT2D ISL1 BCL9 TOX NFAT5 RFX3	3.80e-05	1390	46	12	GO:0045944
GeneOntologyBiologicalProcess	regulation of intracellular steroid hormone receptor signaling pathway	NCOA2 NCOA3 KMT2D ISL1	4.21e-05	87	46	4	GO:0033143
GeneOntologyBiologicalProcess	regulation of cellular response to stress	SETD2 UBQLN2 UBQLN1 POLQ SGTA CD36 UBQLN4 EIF4G1	4.70e-05	598	46	8	GO:0080135
GeneOntologyBiologicalProcess	regulation of intracellular estrogen receptor signaling pathway	NCOA3 KMT2D ISL1	7.04e-05	36	46	3	GO:0033146
GeneOntologyBiologicalProcess	process utilizing autophagic mechanism	SETD2 UBQLN2 UBQLN1 EIF4G3 TBC1D5 CHMP2B UBQLN4 EIF4G1	8.43e-05	650	46	8	GO:0061919
GeneOntologyBiologicalProcess	autophagy	SETD2 UBQLN2 UBQLN1 EIF4G3 TBC1D5 CHMP2B UBQLN4 EIF4G1	8.43e-05	650	46	8	GO:0006914
GeneOntologyBiologicalProcess	nuclear receptor-mediated signaling pathway	TRERF1 NCOA2 NCOA3 KMT2D ISL1	8.48e-05	202	46	5	GO:0141193
GeneOntologyBiologicalProcess	positive regulation of response to endoplasmic reticulum stress	UBQLN2 UBQLN1 SGTA	1.38e-04	45	46	3	GO:1905898
GeneOntologyBiologicalProcess	cellular response to steroid hormone stimulus	TRERF1 NCOA2 NCOA3 KMT2D ISL1	1.86e-04	239	46	5	GO:0071383
GeneOntologyBiologicalProcess	hormone-mediated signaling pathway	TRERF1 NCOA2 NCOA3 KMT2D ISL1	2.05e-04	244	46	5	GO:0009755
GeneOntologyBiologicalProcess	clathrin-dependent endocytosis	AAK1 SMAP1 UBQLN2	2.25e-04	53	46	3	GO:0072583
GeneOntologyBiologicalProcess	myoblast differentiation	BCL9L ISL1 BCL9 MBNL1	2.38e-04	136	46	4	GO:0045445
GeneOntologyBiologicalProcess	regulation of autophagy	SETD2 UBQLN2 UBQLN1 EIF4G3 UBQLN4 EIF4G1	2.49e-04	400	46	6	GO:0010506
GeneOntologyBiologicalProcess	estrogen receptor signaling pathway	NCOA3 KMT2D ISL1	2.79e-04	57	46	3	GO:0030520
GeneOntologyBiologicalProcess	positive regulation of intracellular estrogen receptor signaling pathway	NCOA3 KMT2D	3.17e-04	12	46	2	GO:0033148
GeneOntologyBiologicalProcess	regulation of receptor-mediated endocytosis	AAK1 SMAP1 UBQLN2 TBC1D5	4.01e-04	156	46	4	GO:0048259
GeneOntologyBiologicalProcess	autophagosome maturation	UBQLN1 CHMP2B UBQLN4	4.91e-04	69	46	3	GO:0097352
GeneOntologyCellularComponent	transcription regulator complex	TRERF1 NCOA2 BCL9L NCOA3 NCOA6 ISL1 BCL9 NFAT5 RFX3	4.15e-06	596	45	9	GO:0005667
GeneOntologyCellularComponent	TRC complex	SGTB SGTA	4.53e-06	2	45	2	GO:0072380
GeneOntologyCellularComponent	autophagosome	UBQLN2 UBQLN1 TBC1D5 CHMP2B UBQLN4	5.60e-06	119	45	5	GO:0005776
GeneOntologyCellularComponent	clathrin coat	AAK1 CLINT1 TBC1D5	2.39e-04	56	45	3	GO:0030118
GeneOntologyCellularComponent	MLL3/4 complex	NCOA6 KMT2D	2.95e-04	12	45	2	GO:0044666
GeneOntologyCellularComponent	beta-catenin-TCF complex	BCL9L BCL9	3.48e-04	13	45	2	GO:1990907
GeneOntologyCellularComponent	eukaryotic translation initiation factor 4F complex	EIF4G3 EIF4G1	3.48e-04	13	45	2	GO:0016281
GeneOntologyCellularComponent	ER membrane insertion complex	SGTB SGTA	4.06e-04	14	45	2	GO:0072379
GeneOntologyCellularComponent	nuclear protein-containing complex	TRERF1 NCOA2 BCL9L NCOA3 NCOA6 PRPF38B KMT2D BCL9 CHMP2B UBQLN4	5.68e-04	1377	45	10	GO:0140513
GeneOntologyCellularComponent	RNA cap binding complex	EIF4G3 EIF4G1	6.04e-04	17	45	2	GO:0034518
GeneOntologyCellularComponent	membrane coat	AAK1 CLINT1 TBC1D5	1.54e-03	106	45	3	GO:0030117
GeneOntologyCellularComponent	coated membrane	AAK1 CLINT1 TBC1D5	1.54e-03	106	45	3	GO:0048475
GeneOntologyCellularComponent	RNA polymerase II transcription regulator complex	NCOA2 BCL9L NCOA3 BCL9	2.75e-03	272	45	4	GO:0090575
GeneOntologyCellularComponent	clathrin vesicle coat	CLINT1 TBC1D5	3.03e-03	38	45	2	GO:0030125
GeneOntologyCellularComponent	perinuclear region of cytoplasm	DAB1 NCOA3 CLINT1 UBQLN1 RYR1 UBQLN4 TNRC6A	3.57e-03	934	45	7	GO:0048471
MousePheno	abnormal spleen size	NCOA2 OR1E2 OR1E3 NCOA3 SMAP1 KATNAL2 TOX POLQ NFAT5 CD36 RYR1 CHMP2B UBQLN4 EIF4G1	4.34e-06	1203	41	14	MP:0002224
MousePheno	visceromegaly	NCOA2 OR1E2 OR1E3 NCOA3 SMAP1 NCOA6 KATNAL2 TOX CD36 RYR1 CHMP2B UBQLN4	2.56e-05	1030	41	12	MP:0013328
MousePheno	enlarged spleen	NCOA2 OR1E2 OR1E3 NCOA3 SMAP1 KATNAL2 TOX CD36 RYR1 CHMP2B UBQLN4	2.63e-05	862	41	11	MP:0000691
Domain	Ubiquilin	UBQLN2 UBQLN1 UBQLN4	2.60e-07	6	45	3	IPR015496
Domain	W2	BZW1 EIF4G3 EIF4G1	4.54e-07	7	45	3	PF02020
Domain	W2	BZW1 EIF4G3 EIF4G1	4.54e-07	7	45	3	PS51363
Domain	eIF5C	BZW1 EIF4G3 EIF4G1	4.54e-07	7	45	3	SM00515
Domain	W2_domain	BZW1 EIF4G3 EIF4G1	4.54e-07	7	45	3	IPR003307
Domain	STI1_HS-bd	UBQLN2 UBQLN1 UBQLN4	1.55e-06	10	45	3	IPR006636
Domain	STI1	UBQLN2 UBQLN1 UBQLN4	1.55e-06	10	45	3	SM00727
Domain	SGTA_dimer	SGTB SGTA	5.68e-06	2	45	2	PF16546
Domain	BCL9_beta-catenin-bd_dom	BCL9L BCL9	5.68e-06	2	45	2	IPR024670
Domain	BCL9	BCL9L BCL9	5.68e-06	2	45	2	PF11502
Domain	Ubiquilin-1/2	UBQLN2 UBQLN1	5.68e-06	2	45	2	IPR028430
Domain	SGTA_dimer	SGTB SGTA	5.68e-06	2	45	2	IPR032374
Domain	DUF4927	NCOA2 NCOA3	5.68e-06	2	45	2	PF16279
Domain	DUF4927	NCOA2 NCOA3	5.68e-06	2	45	2	IPR032565
Domain	Bcl-9	BCL9L BCL9	5.68e-06	2	45	2	IPR015668
Domain	MIF4-like	BZW1 EIF4G3 EIF4G1	5.83e-06	15	45	3	IPR016021
Domain	-	BZW1 EIF4G3 EIF4G1	5.83e-06	15	45	3	1.25.40.180
Domain	6-PGluconate_DH_C-like	UBQLN2 UBQLN1 UBQLN4	1.23e-05	19	45	3	IPR008927
Domain	UBA-like	UBQLN2 UBQLN1 UBQLN4 TNRC6A	1.68e-05	64	45	4	IPR009060
Domain	DUF1518	NCOA2 NCOA3	1.70e-05	3	45	2	PF07469
Domain	DUF1518	NCOA2 NCOA3	1.70e-05	3	45	2	IPR010011
Domain	Src1_rcpt_coact	NCOA2 NCOA3	1.70e-05	3	45	2	IPR008955
Domain	Nuclear_rcpt_coactivator	NCOA2 NCOA3	1.70e-05	3	45	2	IPR017426
Domain	DUF1518	NCOA2 NCOA3	1.70e-05	3	45	2	SM01151
Domain	Nuc_rcpt_coact_Ncoa-typ	NCOA2 NCOA3	1.70e-05	3	45	2	IPR014920
Domain	SRC-1	NCOA2 NCOA3	1.70e-05	3	45	2	IPR014935
Domain	SRC-1	NCOA2 NCOA3	1.70e-05	3	45	2	PF08832
Domain	-	NCOA2 NCOA3	1.70e-05	3	45	2	4.10.630.10
Domain	Nuc_rec_co-act	NCOA2 NCOA3	1.70e-05	3	45	2	PF08815
Domain	UBA	UBQLN2 UBQLN1 UBQLN4	5.07e-05	30	45	3	SM00165
Domain	MI	EIF4G3 EIF4G1	8.46e-05	6	45	2	PS51366
Domain	MA3	EIF4G3 EIF4G1	8.46e-05	6	45	2	SM00544
Domain	Nuc_rcpt_coact	NCOA2 NCOA3	8.46e-05	6	45	2	IPR009110
Domain	MA3	EIF4G3 EIF4G1	8.46e-05	6	45	2	PF02847
Domain	Initiation_fac_eIF4g_MI	EIF4G3 EIF4G1	8.46e-05	6	45	2	IPR003891
Domain	UBA	UBQLN2 UBQLN1 UBQLN4	8.83e-05	36	45	3	PF00627
Domain	UBIQUITIN_1	UBQLN2 UBQLN1 UBQLN4	9.59e-05	37	45	3	PS00299
Domain	UBQ	UBQLN2 UBQLN1 UBQLN4	1.51e-04	43	45	3	SM00213
Domain	UBA	UBQLN2 UBQLN1 UBQLN4	1.62e-04	44	45	3	IPR015940
Domain	UBA	UBQLN2 UBQLN1 UBQLN4	1.97e-04	47	45	3	PS50030
Domain	ubiquitin	UBQLN2 UBQLN1 UBQLN4	1.97e-04	47	45	3	PF00240
Domain	MIF4G	EIF4G3 EIF4G1	2.52e-04	10	45	2	SM00543
Domain	MIF4G	EIF4G3 EIF4G1	2.52e-04	10	45	2	PF02854
Domain	MIF4G-like_typ-3	EIF4G3 EIF4G1	2.52e-04	10	45	2	IPR003890
Domain	UBIQUITIN_2	UBQLN2 UBQLN1 UBQLN4	2.97e-04	54	45	3	PS50053
Domain	Ubiquitin_dom	UBQLN2 UBQLN1 UBQLN4	3.68e-04	58	45	3	IPR000626
Domain	Post-SET_dom	SETD2 KMT2D	6.67e-04	16	45	2	IPR003616
Domain	PostSET	SETD2 KMT2D	6.67e-04	16	45	2	SM00508
Domain	POST_SET	SETD2 KMT2D	6.67e-04	16	45	2	PS50868
Domain	ARM-type_fold	BZW1 UBQLN2 UBQLN1 EIF4G3 EIF4G1	1.29e-03	339	45	5	IPR016024
Domain	PAS	NCOA2 NCOA3	1.64e-03	25	45	2	PF00989
Domain	PAS_fold	NCOA2 NCOA3	1.64e-03	25	45	2	IPR013767
Domain	PAS	NCOA2 NCOA3	2.69e-03	32	45	2	SM00091
Domain	PAS	NCOA2 NCOA3	3.03e-03	34	45	2	IPR000014
Domain	PAS	NCOA2 NCOA3	3.03e-03	34	45	2	PS50112
Domain	SET	SETD2 KMT2D	4.38e-03	41	45	2	PF00856
Domain	SET	SETD2 KMT2D	5.49e-03	46	45	2	SM00317
Domain	SET_dom	SETD2 KMT2D	6.46e-03	50	45	2	IPR001214
Domain	SET	SETD2 KMT2D	6.46e-03	50	45	2	PS50280
Pathway	REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION	NCOA2 ZNF638 NCOA3 NCOA6 CD36	3.72e-06	84	40	5	M1008
Pathway	REACTOME_ADIPOGENESIS	NCOA2 ZNF638 NCOA3 NCOA6 CD36	1.40e-05	110	40	5	M48259
Pathway	REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX	BCL9L KMT2D BCL9	5.26e-05	26	40	3	MM14793
Pathway	BIOCARTA_IRES_PATHWAY	EIF4G3 EIF4G1	1.63e-04	7	40	2	M22028
Pathway	REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX	BCL9L KMT2D BCL9	2.25e-04	42	40	3	M27272
Pathway	REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA	NCOA2 NCOA3 NCOA6 CD36	3.38e-04	118	40	4	M27316
Pathway	KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY	NCOA2 NCOA3	4.25e-04	11	40	2	M47503
Pathway	PID_ERB_GENOMIC_PATHWAY	NCOA2 NCOA3	8.05e-04	15	40	2	M119
Pathway	BIOCARTA_EIF_PATHWAY	EIF4G3 EIF4G1	9.19e-04	16	40	2	M7721
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	AAK1 TRERF1 ZNF638 NCOA3 NCOA6 PRPF38B SETD2 KMT2D BCL9 SGTA EIF4G1	4.06e-09	774	46	11	15302935
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	NCOA2 ZNF638 BCL9L NCOA3 NCOA6 KMT2D BCL9 MBNL1 TNRC6A	7.73e-09	457	46	9	32344865
Pubmed	Herp enhances ER-associated protein degradation by recruiting ubiquilins.	UBQLN2 UBQLN1 UBQLN4	8.65e-09	4	46	3	18307982
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TRERF1 NCOA2 NCOA3 NCOA6 PRPF38B CLINT1 KMT2D BZW1 UBQLN1 RESF1 BCL9 MBNL1	1.40e-08	1103	46	12	34189442
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	AAK1 ZNF638 CCP110 NCOA3 BZW1 EIF4G3 SGTA CHMP2B EIF4G1	1.77e-08	503	46	9	16964243
Pubmed	Interaction network of human early embryonic transcription factors.	TRERF1 NCOA2 BCL9L NCOA3 NCOA6 KMT2D RESF1 BCL9	1.86e-08	351	46	8	38297188
Pubmed	RTL8 promotes nuclear localization of UBQLN2 to subnuclear compartments associated with protein quality control.	UBQLN2 UBQLN1 UBQLN4	4.32e-08	6	46	3	35247097
Pubmed	EDEM1 Drives Misfolded Protein Degradation via ERAD and Exploits ER-Phagy as Back-Up Mechanism When ERAD Is Impaired.	UBQLN2 UBQLN1 SGTB SGTA TBC1D5 EIF4G1	4.73e-08	150	46	6	32423001
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	TRERF1 NCOA2 BCL9L NCOA3 NCOA6 KMT2D BCL9	6.18e-08	268	46	7	33640491
Pubmed	Structure of hRpn10 Bound to UBQLN2 UBL Illustrates Basis for Complementarity between Shuttle Factors and Substrates at the Proteasome.	UBQLN2 UBQLN1 UBQLN4	7.55e-08	7	46	3	30664872
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOA2 NCOA3 NCOA6 KMT2D BCL9	8.70e-08	83	46	5	28794006
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	TRERF1 NCOA6 CLINT1 UBQLN2 UBQLN1 BCL9 EIF4G3 TBC1D5	8.85e-08	430	46	8	35044719
Pubmed	Wnt signalling regulates paxillin ubiquitination essential for mesodermal cell motility.	UBQLN2 UBQLN1 SGTA UBQLN4	1.07e-07	33	46	4	17558393
Pubmed	Ubiquilin4 is an adaptor protein that recruits Ubiquilin1 to the autophagy machinery.	UBQLN2 UBQLN1 UBQLN4	1.21e-07	8	46	3	23459205
Pubmed	Human transcription factor protein interaction networks.	TRERF1 NCOA2 ZNF638 BCL9L NCOA3 NCOA6 KMT2D RESF1 BCL9 MBNL1 EIF4G1 TNRC6A	2.35e-07	1429	46	12	35140242
Pubmed	The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome.	NCOA2 NCOA3 NCOA6	3.55e-07	11	46	3	36613751
Pubmed	UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome.	UBQLN2 UBQLN1 UBQLN4	6.14e-07	13	46	3	27477512
Pubmed	Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins.	NCOA2 NCOA6 KMT2D	7.80e-07	14	46	3	12482968
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	TRERF1 NCOA2 ZNF638 NCOA3 TSC22D1 TOX NFAT5 RFX3 MBNL1	9.62e-07	808	46	9	20412781
Pubmed	New nomenclature for chromatin-modifying enzymes.	NCOA2 NCOA3 SETD2 KMT2D	1.00e-06	57	46	4	18022353
Pubmed	MLL3 and MLL4 Methyltransferases Bind to the MAFA and MAFB Transcription Factors to Regulate Islet β-Cell Function.	NCOA6 KMT2D ISL1	1.45e-06	17	46	3	26180087
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	AAK1 DOCK4 CCP110 NCOA6 CLINT1 RESF1 EIF4G3 TBC1D5 EIF4G1	1.62e-06	861	46	9	36931259
Pubmed	Homeostatic levels of SRC-2 and SRC-3 promote early human adipogenesis.	NCOA2 NCOA3	1.71e-06	2	46	2	21220509
Pubmed	Uterine Tumor Resembling Ovarian Sex Cord Tumor: A Distinct Entity Characterized by Recurrent NCOA2/3 Gene Fusions.	NCOA2 NCOA3	1.71e-06	2	46	2	30273195
Pubmed	Targeting BCL9/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration.	BCL9L BCL9	1.71e-06	2	46	2	38811552
Pubmed	Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions.	BCL9L BCL9	1.71e-06	2	46	2	15371335
Pubmed	Autism-Misregulated eIF4G Microexons Control Synaptic Translation and Higher Order Cognitive Functions.	EIF4G3 EIF4G1	1.71e-06	2	46	2	31999954
Pubmed	A new Drosophila model of Ubiquilin knockdown shows the effect of impaired proteostasis on locomotive and learning abilities.	UBQLN2 UBQLN1	1.71e-06	2	46	2	29247619
Pubmed	Towards a molecular understanding of the overlapping and distinct roles of UBQLN1 and UBQLN2 in lung cancer progression and metastasis.	UBQLN2 UBQLN1	1.71e-06	2	46	2	35063704
Pubmed	eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation.	EIF4G3 EIF4G1	1.71e-06	2	46	2	10872469
Pubmed	A novel SRC-2-dependent regulation of epithelial-mesenchymal transition in breast cancer cells.	NCOA2 NCOA3	1.71e-06	2	46	2	30048685
Pubmed	A brain-specific isoform of small glutamine-rich tetratricopeptide repeat-containing protein binds to Hsc70 and the cysteine string protein.	SGTB SGTA	1.71e-06	2	46	2	12878599
Pubmed	Bcl9/Bcl9l are critical for Wnt-mediated regulation of stem cell traits in colon epithelium and adenocarcinomas.	BCL9L BCL9	1.71e-06	2	46	2	20682801
Pubmed	Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer.	NCOA3 NCOA6	1.71e-06	2	46	2	8758910
Pubmed	BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer.	BCL9L BCL9	1.71e-06	2	46	2	33767438
Pubmed	Effects of a Levonorgestrel-Releasing Intrauterine System on the Expression of Steroid Receptor Coregulators in Adenomyosis.	NCOA2 NCOA3	1.71e-06	2	46	2	26040939
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	NCOA2 NCOA3 RESF1 BCL9 TNRC6A	1.77e-06	152	46	5	38360978
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	AAK1 NCOA2 SMAP1 CLINT1 RESF1 TBC1D5 EIF4G1	1.84e-06	444	46	7	34795231
Pubmed	T0070907, a selective ligand for peroxisome proliferator-activated receptor gamma, functions as an antagonist of biochemical and cellular activities.	NCOA2 NCOA3 NCOA6	2.43e-06	20	46	3	11877444
Pubmed	Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor.	NCOA2 NCOA3 NCOA6	2.83e-06	21	46	3	19596656
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	AAK1 DAB1 NCOA2 ZNF638 PRPF38B TSC22D1 EIF4G3 NFAT5 SGTA TBC1D5 MBNL1	2.86e-06	1489	46	11	28611215
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	NCOA2 NCOA3 NCOA6 KMT2D	3.56e-06	78	46	4	28611094
Pubmed	cDNAs with long CAG trinucleotide repeats from human brain.	NCOA3 KMT2D TNRC6A	3.76e-06	23	46	3	9225980
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	BCL9L NCOA3 BCL9 MBNL1 TNRC6A	4.05e-06	180	46	5	35198878
Pubmed	The transcriptional coregulators TIF2 and SRC-1 regulate energy homeostasis by modulating mitochondrial respiration in skeletal muscles.	NCOA2 NCOA3	5.13e-06	3	46	2	21035760
Pubmed	Structural characterization of the Z RING-eIF4E complex reveals a distinct mode of control for eIF4E.	EIF4G3 EIF4G1	5.13e-06	3	46	2	20212144
Pubmed	Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line.	NCOA2 NCOA3	5.13e-06	3	46	2	21059860
Pubmed	Prognostic value of novel biomarkers in astrocytic brain tumors: nuclear receptor co-regulators AIB1, TIF2, and PELP1 are associated with high tumor grade and worse patient prognosis.	NCOA2 NCOA3	5.13e-06	3	46	2	21735116
Pubmed	The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis.	BCL9L BCL9	5.13e-06	3	46	2	34545187
Pubmed	Muscle chloride channel dysfunction in two mouse models of myotonic dystrophy.	RYR1 MBNL1	5.13e-06	3	46	2	17158949
Pubmed	Absence of the steroid receptor coactivator-3 induces B-cell lymphoma.	NCOA2 NCOA3	5.13e-06	3	46	2	16675958
Pubmed	Differential regulation of β-catenin-mediated transcription via N- and C-terminal co-factors governs identity of murine intestinal epithelial stem cells.	BCL9L BCL9	5.13e-06	3	46	2	33649334
Pubmed	FLASH interacts with p160 coactivator subtypes and differentially suppresses transcriptional activity of steroid hormone receptors.	NCOA2 NCOA3	5.13e-06	3	46	2	15698540
Pubmed	Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene.	NCOA2 NCOA3	5.13e-06	3	46	2	9506940
Pubmed	Steroid receptor coactivators present a unique opportunity for drug development in hormone-dependent cancers.	NCOA2 NCOA3	5.13e-06	3	46	2	28390937
Pubmed	Estrogen signaling in colorectal carcinoma microenvironment: expression of ERbeta1, AIB-1, and TIF-2 is upregulated in cancer-associated myofibroblasts and correlates with disease progression.	NCOA2 NCOA3	5.13e-06	3	46	2	19277704
Pubmed	Ubiquitin receptor proteins hHR23a and hPLIC2 interact.	UBQLN2 UBQLN1	5.13e-06	3	46	2	17098253
Pubmed	Research resource: loss of the steroid receptor coactivators confers neurobehavioral consequences.	NCOA2 NCOA3	5.13e-06	3	46	2	23927929
Pubmed	Vitamin D receptor and coactivators SRC2 and 3 regulate epidermis-specific sphingolipid production and permeability barrier formation.	NCOA2 NCOA3	5.13e-06	3	46	2	19052561
Pubmed	Peptide analogs of thymopentin distinguish distinct thymopoietin receptor specificities on two human T cell lines.	SGTB SGTA	5.13e-06	3	46	2	2158125
Pubmed	Expression and significance of androgen receptor coactivators in urothelial carcinoma of the bladder.	NCOA2 NCOA3	5.13e-06	3	46	2	18845648
Pubmed	The function of TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP.	NCOA2 NCOA3	5.13e-06	3	46	2	12138202
Pubmed	Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy.	UBQLN2 UBQLN1	5.13e-06	3	46	2	20529957
Pubmed	The nuclear receptor coactivators p300/CBP/cointegrator-associated protein (p/CIP) and transcription intermediary factor 2 (TIF2) differentially regulate PKA-stimulated transcriptional activity of steroidogenic factor 1.	NCOA2 NCOA3	5.13e-06	3	46	2	11923473
Pubmed	Structure and chromosomal locations of mouse steroid receptor coactivator gene family.	NCOA2 NCOA3	5.13e-06	3	46	2	10501088
Pubmed	A newly identified N-terminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)-dependent translation.	EIF4G3 EIF4G1	5.13e-06	3	46	2	9857202
Pubmed	Allosteric remodelling of the histone H3 binding pocket in the Pygo2 PHD finger triggered by its binding to the B9L/BCL9 co-factor.	BCL9L BCL9	5.13e-06	3	46	2	20637214
Pubmed	The genomic analysis of the impact of steroid receptor coactivators ablation on hepatic metabolism.	NCOA2 NCOA3	5.13e-06	3	46	2	16423883
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	CLINT1 BZW1 TTLL5 MBNL1	5.50e-06	87	46	4	12465718
Pubmed	The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression.	CLINT1 CHMP2B EIF4G1 TNRC6A	8.48e-06	97	46	4	37151849
Pubmed	miR-137 Targets p160 Steroid Receptor Coactivators SRC1, SRC2, and SRC3 and Inhibits Cell Proliferation.	NCOA2 NCOA3	1.03e-05	4	46	2	26066330
Pubmed	P160/SRC/NCoA coactivators form complexes via specific interaction of their PAS-B domain with the CID/AD1 domain.	NCOA2 NCOA3	1.03e-05	4	46	2	18267973
Pubmed	Selective recruitment of p160 coactivators on glucocorticoid-regulated promoters in Schwann cells.	NCOA2 NCOA3	1.03e-05	4	46	2	15331759
Pubmed	Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2.	NCOA2 NCOA3	1.03e-05	4	46	2	10598588
Pubmed	UBQLN2 undergoes a reversible temperature-induced conformational switch that regulates binding with HSPA1B: ALS/FTD mutations cripple the switch but do not destroy HSPA1B binding.	UBQLN2 UBQLN1	1.03e-05	4	46	2	36423739
Pubmed	E6AP AZUL interaction with UBQLN1/2 in cells, condensates, and an AlphaFold-NMR integrated structure.	UBQLN2 UBQLN1	1.03e-05	4	46	2	36827983
Pubmed	BCL9 is an essential component of canonical Wnt signaling that mediates the differentiation of myogenic progenitors during muscle regeneration.	BCL9L BCL9	1.03e-05	4	46	2	19699733
Pubmed	Characterization of a novel small molecule subtype specific estrogen-related receptor alpha antagonist in MCF-7 breast cancer cells.	NCOA2 NCOA3	1.03e-05	4	46	2	19462000
Pubmed	Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity.	NCOA2 NCOA3	1.03e-05	4	46	2	19095746
Pubmed	Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.	NCOA2 NCOA3	1.03e-05	4	46	2	12893883
Pubmed	Estrogen receptor alpha/beta, AIB1, and TIF2 in colorectal carcinogenesis: do coregulators have prognostic significance?	NCOA2 NCOA3	1.03e-05	4	46	2	19198856
Pubmed	Odorant receptors govern the formation of a precise topographic map.	OR1E2 OR1E3	1.03e-05	4	46	2	9546391
Pubmed	PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation.	UBQLN2 UBQLN1	1.03e-05	4	46	2	19148225
Pubmed	Ablation of steroid receptor coactivator-3 resembles the human CACT metabolic myopathy.	NCOA2 NCOA3	1.03e-05	4	46	2	22560224
Pubmed	Interactions of RXR with coactivators are differentially mediated by helix 11 of the receptor's ligand binding domain.	NCOA2 NCOA3	1.03e-05	4	46	2	11851396
Pubmed	Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death.	NCOA2 NCOA3	1.03e-05	4	46	2	26267537
Pubmed	Dimerization of ubiquilin is dependent upon the central region of the protein: evidence that the monomer, but not the dimer, is involved in binding presenilins.	UBQLN2 UBQLN1	1.03e-05	4	46	2	16813565
Pubmed	Reversing chemoresistance by small molecule inhibition of the translation initiation complex eIF4F.	EIF4G3 EIF4G1	1.03e-05	4	46	2	21191102
Pubmed	The molecular mechanisms of coactivator utilization in ligand-dependent transactivation by the androgen receptor.	NCOA2 NCOA3	1.03e-05	4	46	2	15563469
Pubmed	Nuclear hormone receptor coregulator GRIP1 suppresses, whereas SRC1A and p/CIP coactivate, by domain-specific binding of MyoD.	NCOA2 NCOA3	1.03e-05	4	46	2	15563453
Pubmed	Transcription activation by the orphan nuclear receptor, chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI). Definition of the domain involved in the glucocorticoid response of the phosphoenolpyruvate carboxykinase gene.	NCOA2 NCOA3	1.71e-05	5	46	2	10652338
Pubmed	Redundant enhancement of mouse constitutive androstane receptor transactivation by p160 coactivator family members.	NCOA2 NCOA3	1.71e-05	5	46	2	17950690
Pubmed	SIP, a novel ankyrin repeat containing protein, sequesters steroid receptor coactivators in the cytoplasm.	NCOA2 NCOA3	1.71e-05	5	46	2	17476305
Pubmed	Ontogeny of steroid receptor coactivators in the hippocampus and their role in regulating postnatal HPA axis function.	NCOA2 NCOA3	1.71e-05	5	46	2	17854779
Pubmed	Dual role of the arginine methyltransferase CARM1 in the regulation of c-Fos target genes.	NCOA2 NCOA3	1.71e-05	5	46	2	18511550
Pubmed	Estrogen receptor-alpha interaction with the CREB binding protein coactivator is regulated by the cellular environment.	NCOA2 NCOA3	1.71e-05	5	46	2	14766010
Pubmed	Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.	NCOA2 NCOA3	1.71e-05	5	46	2	12714702
Pubmed	LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction.	BCL9L BCL9	1.71e-05	5	46	2	24360964
Pubmed	Human eukaryotic translation initiation factor 4G (eIF4G) recruits mnk1 to phosphorylate eIF4E.	EIF4G3 EIF4G1	1.71e-05	5	46	2	9878069
Pubmed	Regulation of transcription by a protein methyltransferase.	NCOA2 NCOA3	1.71e-05	5	46	2	10381882
Interaction	ZG16 interactions	UBQLN2 UBQLN1 SGTB SGTA UBQLN4	3.07e-11	12	44	5	int:ZG16
Interaction	SERPINI2 interactions	UBQLN2 UBQLN1 SGTB SGTA UBQLN4	3.29e-10	18	44	5	int:SERPINI2
Interaction	SRGN interactions	UBQLN2 UBQLN1 SGTB SGTA UBQLN4	5.94e-10	20	44	5	int:SRGN
Interaction	WFDC12 interactions	UBQLN2 UBQLN1 SGTB SGTA	1.37e-09	8	44	4	int:WFDC12
Interaction	PPIC interactions	UBQLN2 UBQLN1 SGTB SGTA UBQLN4	2.49e-09	26	44	5	int:PPIC
Interaction	EGR2 interactions	TRERF1 NCOA2 BCL9L NCOA3 NCOA6 KMT2D RESF1 BCL9	3.12e-09	171	44	8	int:EGR2
Interaction	PAX9 interactions	NCOA2 BCL9L NCOA3 NCOA6 KMT2D BCL9 MBNL1	1.24e-08	130	44	7	int:PAX9
Interaction	SOD3 interactions	UBQLN2 UBQLN1 SGTB SGTA	1.39e-08	13	44	4	int:SOD3
Interaction	SP7 interactions	TRERF1 NCOA2 ZNF638 BCL9L NCOA3 NCOA6 KMT2D BCL9 MBNL1	1.60e-08	304	44	9	int:SP7
Interaction	ITPRIPL1 interactions	UBQLN2 UBQLN1 SGTB SGTA UBQLN4	2.44e-08	40	44	5	int:ITPRIPL1
Interaction	PRAP1 interactions	UBQLN2 UBQLN1 SGTB SGTA	5.91e-08	18	44	4	int:PRAP1
Interaction	TLE3 interactions	TRERF1 NCOA2 BCL9L NCOA3 SETD2 KMT2D BCL9 MBNL1 TNRC6A	9.92e-08	376	44	9	int:TLE3
Interaction	SERPINE1 interactions	UBQLN2 UBQLN1 SGTB SGTA UBQLN4	1.15e-07	54	44	5	int:SERPINE1
Interaction	DEFA6 interactions	UBQLN2 UBQLN1 SGTB SGTA	1.70e-07	23	44	4	int:DEFA6
Interaction	DMKN interactions	UBQLN2 UBQLN1 SGTB SGTA	2.42e-07	25	44	4	int:DMKN
Interaction	ETNK1 interactions	UBQLN2 UBQLN1 SGTB SGTA	2.42e-07	25	44	4	int:ETNK1
Interaction	EDEM1 interactions	BZW1 UBQLN2 UBQLN1 SGTB SGTA TBC1D5 EIF4G1	2.56e-07	202	44	7	int:EDEM1
Interaction	NUP35 interactions	NCOA2 ZNF638 BCL9L NCOA3 NCOA6 KMT2D BCL9 MBNL1 TNRC6A	2.74e-07	424	44	9	int:NUP35
Interaction	MYDGF interactions	UBQLN2 UBQLN1 SGTB SGTA UBQLN4	3.18e-07	66	44	5	int:MYDGF
Interaction	PSORS1C2 interactions	UBQLN2 UBQLN1 SGTB SGTA	4.51e-07	29	44	4	int:PSORS1C2
Interaction	ERP27 interactions	UBQLN2 UBQLN1 SGTA UBQLN4	5.20e-07	30	44	4	int:ERP27
Interaction	FZD7 interactions	UBQLN2 UBQLN1 SGTB SGTA UBQLN4	6.90e-07	77	44	5	int:FZD7
Interaction	COL1A2 interactions	UBQLN2 UBQLN1 SGTB SGTA CD36	7.36e-07	78	44	5	int:COL1A2
Interaction	MAP1LC3A interactions	CLINT1 UBQLN2 UBQLN1 RESF1 BCL9 TBC1D5 UBQLN4	8.43e-07	241	44	7	int:MAP1LC3A
Interaction	EYA4 interactions	AAK1 NCOA2 NCOA3 UBQLN2 RESF1 BCL9 TNRC6A	8.91e-07	243	44	7	int:EYA4
Interaction	SOX2 interactions	TRERF1 NCOA2 ZNF638 BCL9L NCOA3 NCOA6 SETD2 CLINT1 KMT2D BCL9 EIF4G3 RFX3 RYR1 TNRC6A	1.09e-06	1422	44	14	int:SOX2
Interaction	CRX interactions	TRERF1 NCOA2 BCL9L NCOA3 SMAP1 KMT2D BCL9	1.20e-06	254	44	7	int:CRX
Interaction	SLPI interactions	UBQLN2 UBQLN1 SGTB SGTA	1.24e-06	37	44	4	int:SLPI
Interaction	CD99L2 interactions	UBQLN2 UBQLN1 SGTB SGTA	1.54e-06	39	44	4	int:CD99L2
Interaction	LHX4 interactions	NCOA2 BCL9L KMT2D ISL1 UBQLN1 BCL9	1.55e-06	166	44	6	int:LHX4
Interaction	PLAAT3 interactions	UBQLN2 UBQLN1 UBQLN4	1.58e-06	11	44	3	int:PLAAT3
Interaction	AGR3 interactions	UBQLN2 UBQLN1 SGTB SGTA	1.71e-06	40	44	4	int:AGR3
Interaction	TFF1 interactions	NCOA3 UBQLN1 SGTB UBQLN4	1.89e-06	41	44	4	int:TFF1
Interaction	SOX17 interactions	NCOA2 NCOA3 NCOA6 KMT2D BCL9	1.97e-06	95	44	5	int:SOX17
Interaction	FGF21 interactions	SGTB SGTA KLB	2.11e-06	12	44	3	int:FGF21
Interaction	NME3 interactions	UBQLN2 UBQLN1 SGTB SGTA UBQLN4	2.53e-06	100	44	5	int:NME3
Interaction	YWHAH interactions	AAK1 NCOA2 DOCK4 ZNF638 CCP110 NCOA3 NCOA6 CLINT1 RESF1 EIF4G3 TBC1D5 EIF4G1	2.78e-06	1102	44	12	int:YWHAH
Interaction	PTN interactions	TSC22D1 UBQLN1 SGTA RYR1 UBQLN4	4.24e-06	111	44	5	int:PTN
Interaction	IGFBP6 interactions	UBQLN2 UBQLN1 SGTA UBQLN4	4.58e-06	51	44	4	int:IGFBP6
Interaction	TBR1 interactions	NCOA2 BCL9L NCOA3 KMT2D BCL9	4.62e-06	113	44	5	int:TBR1
Interaction	TBXT interactions	NCOA2 NCOA3 NCOA6 KMT2D BCL9	5.26e-06	116	44	5	int:TBXT
Interaction	GUCA2A interactions	UBQLN2 UBQLN1 SGTA	5.33e-06	16	44	3	int:GUCA2A
Interaction	HSPA13 interactions	UBQLN2 UBQLN1 SGTB SGTA UBQLN4	6.73e-06	122	44	5	int:HSPA13
Interaction	DTX2 interactions	BCL9L NCOA3 BCL9 MBNL1 UBQLN4 EIF4G1 TNRC6A	6.75e-06	330	44	7	int:DTX2
Interaction	CDSN interactions	UBQLN2 UBQLN1 SGTB SGTA UBQLN4	7.29e-06	124	44	5	int:CDSN
Interaction	ERP29 interactions	UBQLN2 UBQLN1 SGTB SGTA UBQLN4	7.29e-06	124	44	5	int:ERP29
Interaction	SSBP4 interactions	BCL9L ISL1 BCL9 MBNL1	8.24e-06	59	44	4	int:SSBP4
Interaction	ERG interactions	NCOA2 NCOA3 NCOA6 KMT2D RESF1 BCL9	8.53e-06	223	44	6	int:ERG
Interaction	CDH15 interactions	UBQLN2 SGTB SGTA	9.18e-06	19	44	3	int:CDH15
Interaction	CEBPA interactions	TRERF1 NCOA2 NCOA3 NCOA6 PRPF38B CLINT1 KMT2D BZW1 UBQLN1 RESF1 BCL9 MBNL1	9.74e-06	1245	44	12	int:CEBPA
Interaction	RAI2 interactions	UBQLN1 SGTB UBQLN4	1.08e-05	20	44	3	int:RAI2
Interaction	EFEMP2 interactions	ZNF638 UBQLN1 SGTB SGTA UBQLN4	1.14e-05	136	44	5	int:EFEMP2
Interaction	SOX15 interactions	NCOA2 NCOA3 KMT2D BCL9 MBNL1	1.36e-05	141	44	5	int:SOX15
Interaction	GPX7 interactions	UBQLN2 SGTB SGTA UBQLN4	1.37e-05	67	44	4	int:GPX7
Interaction	SMIM2 interactions	UBQLN2 UBQLN1	1.40e-05	3	44	2	int:SMIM2
Interaction	DEFB115 interactions	UBQLN2 UBQLN1	1.40e-05	3	44	2	int:DEFB115
Interaction	SLC5A10 interactions	UBQLN1 UBQLN4	1.40e-05	3	44	2	int:SLC5A10
Interaction	ZG16B interactions	UBQLN2 UBQLN1 SGTB SGTA UBQLN4	1.41e-05	142	44	5	int:ZG16B
Interaction	ETV4 interactions	NCOA2 NCOA3 KMT2D BCL9	1.54e-05	69	44	4	int:ETV4
Interaction	VIP interactions	UBQLN2 SGTA UBQLN4	1.67e-05	23	44	3	int:VIP
Interaction	NAXD interactions	UBQLN2 UBQLN1 SGTB SGTA	1.73e-05	71	44	4	int:NAXD
Interaction	C1QA interactions	UBQLN2 UBQLN1 SGTB SGTA	2.38e-05	77	44	4	int:C1QA
Interaction	SCG5 interactions	UBQLN2 UBQLN1 UBQLN4	2.44e-05	26	44	3	int:SCG5
Interaction	IGLC1 interactions	UBQLN1 SGTA UBQLN4	2.44e-05	26	44	3	int:IGLC1
Interaction	CTAG1A interactions	UBQLN2 UBQLN1 SGTB SGTA	2.64e-05	79	44	4	int:CTAG1A
Interaction	MAFA interactions	NCOA6 KMT2D ISL1	2.74e-05	27	44	3	int:MAFA
Interaction	UPK3A interactions	SGTB SGTA	2.79e-05	4	44	2	int:UPK3A
Interaction	NPVF interactions	UBQLN2 SGTA	2.79e-05	4	44	2	int:NPVF
Interaction	SOX7 interactions	NCOA2 NCOA3 KMT2D RESF1	3.05e-05	82	44	4	int:SOX7
Interaction	PYGO1 interactions	BCL9L ISL1 BCL9	3.06e-05	28	44	3	int:PYGO1
Interaction	RBFOX2 interactions	DAB1 PRPF38B UBQLN2 EIF4G3 MBNL1 TNRC6A	3.34e-05	284	44	6	int:RBFOX2
Interaction	GAL interactions	UBQLN2 UBQLN1 SGTA	3.41e-05	29	44	3	int:GAL
Interaction	TLX3 interactions	NCOA2 BCL9L NCOA3 NCOA6 KMT2D BCL9	3.83e-05	291	44	6	int:TLX3
Interaction	GSC interactions	BCL9L NCOA3 KMT2D BCL9	3.85e-05	87	44	4	int:GSC
Interaction	PRB4 interactions	SGTB SGTA	4.64e-05	5	44	2	int:PRB4
Interaction	IGL interactions	UBQLN1 SGTA	4.64e-05	5	44	2	int:IGL
Interaction	GUCA2B interactions	UBQLN2 UBQLN1	4.64e-05	5	44	2	int:GUCA2B
Interaction	ALG13 interactions	NCOA2 NCOA3 KMT2D BCL9 TNRC6A	4.76e-05	183	44	5	int:ALG13
Interaction	SOX10 interactions	NCOA2 NCOA3 KMT2D BCL9	4.80e-05	92	44	4	int:SOX10
Interaction	VIM interactions	AAK1 DOCK4 CCP110 TSC22D1 UBQLN2 RESF1 MBNL1 EIF4G1 TNRC6A	4.94e-05	804	44	9	int:VIM
Interaction	FOS interactions	NCOA2 NCOA3 NCOA6 KMT2D BCL9 NFAT5	5.65e-05	312	44	6	int:FOS
Interaction	SOX9 interactions	NCOA3 NCOA6 KMT2D BCL9	5.91e-05	97	44	4	int:SOX9
Interaction	MIEF2 interactions	UBQLN2 UBQLN1 UBQLN4	6.05e-05	35	44	3	int:MIEF2
Interaction	SMG7 interactions	NCOA2 NCOA3 NCOA6 KMT2D BCL9 TNRC6A	6.38e-05	319	44	6	int:SMG7
Interaction	KLF5 interactions	NCOA2 NCOA3 NCOA6 KMT2D BCL9	6.44e-05	195	44	5	int:KLF5
Interaction	PAGE3 interactions	SGTB SGTA	6.95e-05	6	44	2	int:PAGE3
Interaction	C1QTNF4 interactions	UBQLN2 UBQLN1	6.95e-05	6	44	2	int:C1QTNF4
Interaction	C1QTNF5 interactions	SGTB SGTA	6.95e-05	6	44	2	int:C1QTNF5
Interaction	COL10A1 interactions	UBQLN2 UBQLN1 SGTB	7.77e-05	38	44	3	int:COL10A1
Interaction	FEV interactions	NCOA2 NCOA3 NCOA6 KMT2D BCL9	7.79e-05	203	44	5	int:FEV
Interaction	CSTF2T interactions	CLINT1 UBQLN2 UBQLN1 UBQLN4	8.05e-05	105	44	4	int:CSTF2T
Interaction	RNF144B interactions	UBQLN1 SGTB SGTA	8.40e-05	39	44	3	int:RNF144B
Interaction	GALP interactions	UBQLN2 SGTA	9.72e-05	7	44	2	int:GALP
Interaction	TFF3 interactions	UBQLN2 SGTA	9.72e-05	7	44	2	int:TFF3
Interaction	TMEM123 interactions	UBQLN2 SGTB	9.72e-05	7	44	2	int:TMEM123
Interaction	SMIM19 interactions	UBQLN2 UBQLN1	9.72e-05	7	44	2	int:SMIM19
Interaction	OR6T1 interactions	UBQLN2 UBQLN1 UBQLN4	9.77e-05	41	44	3	int:OR6T1
Interaction	ISL1 interactions	BCL9L ISL1 BCL9	9.77e-05	41	44	3	int:ISL1
Interaction	ISL2 interactions	BCL9L ISL1 BCL9	9.77e-05	41	44	3	int:ISL2
Interaction	YAP1 interactions	TRERF1 BCL9L NCOA6 SETD2 CLINT1 KMT2D UBQLN2 UBQLN1 NFAT5 CHMP2B	9.83e-05	1095	44	10	int:YAP1
GeneFamily	Ubiquilin family	UBQLN2 UBQLN1 UBQLN4	4.55e-08	5	31	3	783
GeneFamily	Ataxins\|Trinucleotide repeat containing	NCOA3 KMT2D TNRC6A	1.02e-05	25	31	3	775
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA2 NCOA3	3.81e-04	17	31	2	486
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	SETD2 KMT2D	1.54e-03	34	31	2	487
GeneFamily	Olfactory receptors, family 1	OR1E2 OR1E3	2.13e-03	40	31	2	147
GeneFamily	Basic helix-loop-helix proteins	NCOA2 NCOA3	1.52e-02	110	31	2	420
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	SGTB SGTA	1.65e-02	115	31	2	769
Coexpression	KIM_GERMINAL_CENTER_T_HELPER_UP	ZNF638 PRPF38B RESF1 TOX	4.88e-06	64	46	4	M1405
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	AAK1 TRERF1 ZNF638 NCOA3 PRPF38B SETD2 KMT2D BZW1 RESF1 TOX NFAT5 MBNL1	7.06e-06	1492	46	12	M40023
Coexpression	LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB	NCOA2 EIF4G3 NFAT5 RFX3 TBC1D5	1.16e-05	169	46	5	M39230
Coexpression	GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN	TRERF1 NCOA2 NCOA6 TOX NFAT5	2.49e-05	198	46	5	M6511
Coexpression	GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN	AAK1 DOCK4 PRPF38B TSC22D1 NFAT5	2.55e-05	199	46	5	M7965
Coexpression	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	NCOA3 TOX RFX3 TBC1D5 MBNL1	2.55e-05	199	46	5	M1746
Coexpression	ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	NCOA3 TOX RFX3 TBC1D5 MBNL1	2.62e-05	200	46	5	MM1033
Coexpression	IKEDA_MIR133_TARGETS_UP	NCOA6 EIF4G3 NFAT5	6.37e-05	44	46	3	M2377
Coexpression	IKEDA_MIR133_TARGETS_UP	NCOA6 EIF4G3 NFAT5	6.82e-05	45	46	3	MM929
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	NCOA2 DOCK4 ZNF638 NCOA3 SETD2 CLINT1 EIF4G3 MBNL1	1.09e-04	856	46	8	M4500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	NCOA2 SMAP1 NCOA6 PRPF38B SGTB TOX POLQ TBC1D5	1.80e-07	311	43	8	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	AAK1 DAB1 TRERF1 NCOA2 PRPF38B KATNAL2 ENOX1 SGTB TOX POLQ	5.49e-07	654	43	10	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000	DAB1 TRERF1 NCOA2 PRPF38B KATNAL2 ISL1 ENOX1 SGTB BCL9 TOX POLQ	2.91e-06	983	43	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	ZNF638 CCP110 SMAP1 NCOA6 PRPF38B KATNAL2 RESF1 SGTB BCL9 TOX RFX3 MBNL1	4.66e-06	1252	43	12	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	DAB1 NCOA2 CCP110 SMAP1 PRPF38B KATNAL2 ISL1 SGTB BCL9 TOX RFX3	6.00e-06	1060	43	11	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	NCOA2 SMAP1 NCOA6 PRPF38B KATNAL2 SETD2 SGTB TOX POLQ TBC1D5	2.16e-05	989	43	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_500	DAB1 ISL1 BCL9 NFAT5	3.14e-05	89	43	4	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500_k2
CoexpressionAtlas	DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#4_top-relative-expression-ranked_1000	DAB1 ISL1 UBQLN1 SGTB BCL9 EIF4G3	3.63e-05	311	43	6	gudmap_developingKidney_e13.5_podocyte cells_1000_k4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4	NCOA2 SMAP1 PRPF38B BCL9	6.01e-05	105	43	4	Facebase_RNAseq_e10.5_Medial Nasal Eminence_500_K4
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	DAB1 NCOA2 CCP110 SMAP1 PRPF38B KATNAL2 ISL1 SGTB BCL9 TOX RFX3	8.69e-05	1414	43	11	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	DAB1 ZNF638 KATNAL2 UBQLN2 SGTB POLQ RFX3	8.78e-05	532	43	7	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	TRERF1 PRPF38B ENOX1 BCL9 TOX	1.35e-04	246	43	5	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1	NCOA2 NCOA3 SMAP1 NCOA6 PRPF38B SETD2 SGTB TTLL5	1.48e-04	780	43	8	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	DAB1 CCP110 SMAP1 NCOA6 PRPF38B KATNAL2 UBQLN2 SGTB BCL9 TOX	1.62e-04	1257	43	10	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1	ZNF638 CCP110 KATNAL2 UBQLN2 RFX3	1.71e-04	259	43	5	Facebase_RNAseq_e8.5_Floor Plate_1000_K1
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_500	DAB1 DOCK4 RESF1 NFAT5	2.26e-04	148	43	4	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	NCOA2 NCOA6 KATNAL2 SETD2 SGTB TOX POLQ TBC1D5	2.28e-04	831	43	8	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000	SMAP1 ISL1 BZW1 UBQLN1 RESF1 NFAT5 UBQLN4 EIF4G1	2.54e-04	844	43	8	gudmap_developingGonad_e11.5_testes and mesonephros_1000
CoexpressionAtlas	DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000	DAB1 ISL1 UBQLN1 SGTB BCL9 EIF4G3 NFAT5 CD36	2.77e-04	855	43	8	gudmap_developingKidney_e13.5_podocyte cells_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	NCOA2 ZNF638 SMAP1 PRPF38B BCL9	3.27e-04	298	43	5	Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500	DAB1 PRPF38B KATNAL2 ISL1 ENOX1 TOX	4.47e-04	493	43	6	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	DAB1 NCOA2 KATNAL2 SGTB POLQ	5.07e-04	328	43	5	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	DAB1 CCP110 SMAP1 NCOA6 PRPF38B KATNAL2 UBQLN2 SGTB BCL9 TOX	5.38e-04	1459	43	10	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#2	KATNAL2 ENOX1 TOX	5.49e-04	79	43	3	Facebase_RNAseq_e10.5_Maxillary Arch_500_K2
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000	SMAP1 BZW1 UBQLN1 NFAT5 UBQLN4 EIF4G1	6.74e-04	533	43	6	gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5	DAB1 KATNAL2 SGTB POLQ	7.61e-04	204	43	4	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	SMAP1 PRPF38B RESF1 NFAT5 MBNL1	7.63e-04	359	43	5	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K4
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NCOA2 DOCK4 EIF4G3 NFAT5 TBC1D5 MBNL1	3.55e-08	193	44	6	779276e775cb2492e8dd36436295a536084a6415
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF638 SETD2 CLINT1 EIF4G3 MBNL1	1.03e-06	184	44	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	ZNF638 NFAT5 RFX3 MBNL1 TNRC6A	1.31e-06	193	44	5	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	(1)_T_cells-(1)_T_CD4_naive\|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1)	AAK1 ZNF638 SETD2 RESF1 MBNL1	1.38e-06	195	44	5	d3fa551bc6f5ee5890af1040415e61ecd5d46201
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	SETD2 CLINT1 BZW1 RESF1 MBNL1	1.56e-06	200	44	5	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	facs-Large_Intestine-Proximal-18m-Epithelial-enteroendocrine_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ISL1 ENOX1 CD36 KLB	2.97e-05	180	44	4	9db9899ca42455310e9b63df523fe6c4780abfb7
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-T_cells-Treg\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AAK1 RESF1 TOX MBNL1	3.03e-05	181	44	4	a6c8b33a392de3df2f179317e329e45d3d8c6f52
ToppCell	pdx-Tumor_cells-T0\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	DAB1 NCOA3 NFAT5 KLB	3.30e-05	185	44	4	1d874608aa2062024323512f68889219471b2f00
ToppCell	E12.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast\|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DAB1 TSC22D1 ISL1 TOX	3.52e-05	188	44	4	9b95730ddd13eb4624321bab3ab4989414977ca3
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	AAK1 TRERF1 RESF1 TOX	3.59e-05	189	44	4	df30478b288084a1bd48f660409dcc784040897c
ToppCell	renal_medulla_nuclei-Adult_normal_reference\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	AAK1 DOCK4 EIF4G3 TBC1D5	3.67e-05	190	44	4	f1363f7806cfc4f14fbc1b0e8dac2de813a88eee
ToppCell	NS-moderate-d_16-33-Lymphoid-Treg\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	AAK1 PRPF38B TOX MBNL1	3.82e-05	192	44	4	48d557071bad80edd3ec6e5ad8dcd97037da9553
ToppCell	moderate-Lymphoid-Treg\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	AAK1 PRPF38B TOX MBNL1	3.82e-05	192	44	4	e370ff5aaff7b7042ba9aaf93de43aa563b8b9f9
ToppCell	droplet-Pancreas-Endocrine\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TSC22D1 ISL1 EIF4G1 TNRC6A	3.82e-05	192	44	4	0dfd1e9896c34aee0f842f8de5d0e3af62a15f68
ToppCell	control-Lymphoid-CTL\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	AAK1 PRPF38B RESF1 MBNL1	3.90e-05	193	44	4	89d407a88b5956559a589425b89b3eb8dc78e1dd
ToppCell	Mild-CD8+_T\|World / Disease group and Cell class	AAK1 RESF1 TOX MBNL1	3.98e-05	194	44	4	d64c2efb482bcdef9240977eae1023c4191286e7
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA2 DOCK4 TOX TBC1D5	4.14e-05	196	44	4	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA2 DOCK4 TOX TBC1D5	4.30e-05	198	44	4	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	LPS_only-Epithelial_airway-airway_epithelial-Ciliated\|LPS_only / Treatment groups by lineage, cell group, cell type	CCP110 KATNAL2 ARHGEF33 KLB	4.30e-05	198	44	4	6d90b541fde357fbb40f8f7d4e8628a48b679718
ToppCell	moderate-Lymphoid-CTL\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	AAK1 PRPF38B RESF1 MBNL1	4.30e-05	198	44	4	0a868098b1ee4b28b2149ed766acb09e9c0ce14c
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	NCOA2 EIF4G3 TBC1D5 TNRC6A	4.39e-05	199	44	4	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	control-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	PRPF38B TSC22D1 NFAT5 CD36	4.39e-05	199	44	4	3d01f90ffd271ca00129192787e4921bdca7e01e
ToppCell	control-Epithelial-Secretory\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	TSC22D1 CLINT1 NFAT5 CD36	4.39e-05	199	44	4	262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a
Computational	Genes upregulated in subsets of cells of a given type within various tumors	ZNF638 SETD2 CLINT1	5.12e-04	50	34	3	GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN
Computational	Genes upregulated in subsets of cells of a given type within various tumors	PRPF38B RESF1 MBNL1	5.12e-04	50	34	3	GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_1
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	NCOA3 NFAT5 TBC1D5 MBNL1 CHMP2B EIF4G1	1.57e-06	179	46	6	4585_DN
Drug	glutamin	NCOA3 UBQLN2 UBQLN1 NFAT5 SGTA MBNL1 CHMP2B UBQLN4	3.53e-06	461	46	8	CID000000738
Disease	frontotemporal dementia (implicated_via_orthology)	UBQLN2 UBQLN1 CHMP2B UBQLN4	2.11e-09	12	44	4	DOID:9255 (implicated_via_orthology)
Disease	amyotrophic lateral sclerosis type 15 (implicated_via_orthology)	UBQLN2 UBQLN1 UBQLN4	3.09e-09	3	44	3	DOID:0060206 (implicated_via_orthology)
Disease	amyotrophic lateral sclerosis (implicated_via_orthology)	UBQLN2 UBQLN1 UBQLN4	1.22e-05	30	44	3	DOID:332 (implicated_via_orthology)
Disease	Phyllodes Tumor	SETD2 KMT2D	2.17e-05	5	44	2	C0010701
Disease	Malignant Cystosarcoma Phyllodes	SETD2 KMT2D	2.17e-05	5	44	2	C0600066
Disease	polycystic ovary syndrome (implicated_via_orthology)	NCOA2 CD36	3.25e-05	6	44	2	DOID:11612 (implicated_via_orthology)
Disease	platelet glycoprotein 4 measurement	TBC1D5 CD36	3.25e-05	6	44	2	EFO_0008262
Disease	total blood protein measurement	NCOA2 ZNF638 NCOA3 SETD2 KMT2D MBNL1	5.19e-05	449	44	6	EFO_0004536
Disease	risk-taking behaviour	DAB1 TOX EIF4G3 NFAT5 TBC1D5 UBQLN4 TNRC6A	1.26e-04	764	44	7	EFO_0008579
Disease	malignant pleural mesothelioma (is_marker_for)	NCOA2 SETD2	1.96e-04	14	44	2	DOID:7474 (is_marker_for)
Disease	age at menarche	AAK1 EIF4G3 NFAT5 TBC1D5 EIF4G1 TNRC6A	2.39e-04	594	44	6	EFO_0004703
Disease	response to acetylsalicylate	DAB1 SETD2	2.57e-04	16	44	2	GO_1903492
Disease	smoking status measurement	DAB1 ISL1 TOX EIF4G3 NFAT5 RFX3 TBC1D5 TNRC6A	2.80e-04	1160	44	8	EFO_0006527
Disease	progranulin measurement	NCOA2 UBQLN1	4.93e-04	22	44	2	EFO_0004625
Disease	amyotrophic lateral sclerosis (is_implicated_in)	UBQLN2 CHMP2B	1.05e-03	32	44	2	DOID:332 (is_implicated_in)
Disease	Mammary Carcinoma, Human	TRERF1 NCOA2 NCOA3 SETD2 KMT2D	1.07e-03	525	44	5	C4704874
Disease	Mammary Neoplasms, Human	TRERF1 NCOA2 NCOA3 SETD2 KMT2D	1.07e-03	525	44	5	C1257931
Disease	Mammary Neoplasms	TRERF1 NCOA2 NCOA3 SETD2 KMT2D	1.09e-03	527	44	5	C1458155
Disease	Breast Carcinoma	TRERF1 NCOA2 NCOA3 SETD2 KMT2D	1.19e-03	538	44	5	C0678222
Disease	stomach cancer (is_marker_for)	NCOA2 SETD2 KMT2D	1.25e-03	142	44	3	DOID:10534 (is_marker_for)
Disease	neurodegenerative disease (implicated_via_orthology)	UBQLN2 UBQLN1 UBQLN4	1.33e-03	145	44	3	DOID:1289 (implicated_via_orthology)
Disease	type 2 diabetes mellitus (biomarker_via_orthology)	NCOA6 ISL1 CD36	1.38e-03	147	44	3	DOID:9352 (biomarker_via_orthology)
Disease	prostate cancer (is_marker_for)	NCOA2 NCOA3 KMT2D	1.64e-03	156	44	3	DOID:10283 (is_marker_for)
Disease	Parkinson's disease (implicated_via_orthology)	AAK1 EIF4G3 EIF4G1	1.67e-03	157	44	3	DOID:14330 (implicated_via_orthology)
Disease	response to fenofibrate	DOCK4 CD36	2.54e-03	50	44	2	GO_1901557
Disease	taste liking measurement	EIF4G3 RFX3 TBC1D5 KLB	2.64e-03	388	44	4	EFO_0010155

Protein segments in the cluster

Peptide	Gene	Start	Entry
MNNQKQQKPTLSGQR	BZW1	1	Q7L1Q6
LMTQQAALQQKPTMA	AAK1	556	Q2M2I8
SQQQQSLMESMQPGK	ARHGEF33	521	A8MVX0
MDPQKTLQTMQNFQK	CHMP2B	116	Q9UQN3
PSLNTMIQQQNMQQP	CLINT1	501	Q14677
RMMNDSCQNLPKINQ	KATNAL2	111	Q8IYT4
QQSNMAPMNQEQQPM	NFAT5	1311	O94916
LLQQNPMIEQIMTNQ	NCOA6	706	Q14686
IMTNQMQGNKQQFNT	NCOA6	716	Q14686
QTRQMQNINPLTMCL	DOCK4	1491	Q8N1I0
QQPLVQQQMVMGAQP	DAB1	346	O75553
VMMNSSNIQVKQRGP	CD36	76	P16671
NLNVNMGSNSQMIPQ	BCL9	721	O00512
AGIMQKSLVQQNSMN	POLQ	1351	O75417
NMNLNVQMTPQQQML	BCL9L	781	Q86UU0
SPLLMQNQNTRQQMD	CCP110	551	O43303
LTPQMFQQLMKQVTQ	EIF4G1	771	Q04637
INGRNNLIQQKNMAM	MBNL1	81	Q9NR56
PLNTMAKMGQNVSLN	KLB	381	Q86Z14
NLMIQSIGNIMNNKV	RYR1	2176	P21817
KDQQLQFLQQTMQGM	ENOX1	466	Q8TC92
TPQMFNQLMKQVSGL	EIF4G3	766	O43432
VTMPKLLQNMQNQDP	OR1E2	76	P47887
VTMPKLLQNMQSQNP	OR1E3	76	Q8WZA6
MSMASNLMNNPQIQQ	SGTA	231	O43765
NLMNNPQIQQLMSGM	SGTA	236	O43765
SNAMNNIPQRMIQTK	RFX3	471	P48380
MNPNTQMTGNQLNLK	RESF1	616	Q9HCM1
QMTGNQLNLKNMETP	RESF1	621	Q9HCM1
TTMPKMLVNIQAQAQ	OR7G3	76	Q8NG95
NSMMNQMNQQGNFPL	NCOA3	1136	Q9Y6Q9
QSGMSQPVMQQLDSQ	SATL1	131	Q86VE3
QLQYGQQQPMVSTQM	TSC22D1	626	Q15714
IMMKQLQQQQPNDKT	ISL1	241	P61371
DLKMGNLQNSPVNMN	NCOA2	556	Q15596
GNEKTMNLNPMILTN	PRPF38B	51	Q5VTL8
LQQITENPQLMQNML	UBQLN1	381	Q9UMX0
QPQWSLSQMNQQMAG	SMAP1	416	Q8IYB5
KQQQQMQNLGMTSPL	SETD2	2136	Q9BYW2
SMAASLMQNPQVQQL	SGTB	226	Q96EQ0
QQQQQRLMKSESMPV	TBC1D5	511	Q92609
AMQALMQIQQGLQTL	UBQLN2	451	Q9UHD9
LQQQMQRQLMSNPEM	UBQLN4	181	Q9NRR5
PTGASSAQQQLMQQM	UBQLN4	526	Q9NRR5
MQQPLGNQLPMQVQS	TOX	441	O94900
DQQGRPLSVQQQMMQ	TNRC6A	1441	Q8NDV7
PLSVQQQMMQQSRQL	TNRC6A	1446	Q8NDV7
QTMSQSLIPPSMNQQ	ZNF638	321	Q14966
LMQILQDNGNLSKMQ	TTLL5	661	Q6EMB2
LQAPQMLSQHMQQMQ	TRERF1	251	Q96PN7
MKPQQLAMQQQLANS	KMT2D	3391	O14686